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ABSTRACT: Ectopic ACTH secretion is provoked by extra-pituitary tumours that secrete ACTH, constituting 
an infrequent type of Cushing Syndrome in the dog. Neuroendocrine tumours (NET) are characterised by the 
synthesis of peptides with hormone activity. A dog with clinical diagnosis of Cushing’s syndrome and presenting 
an abdominal tumour located in the area of the left adrenal gland was sent to the hospital. Cortisol was not inhib-
ited at four and eight hours after the application of low-dose dexamethasone and the cortisol/creatinine ratio was 
elevated (93 × 10-6, reference values < 10 × 10–6). Plasma ACTH measurements were high (28.6 pmol/l, reference 
values 5.5–14.3 pmol/l). On computed tomography, the tumour was found in the meso-epigastrium, with both 
adrenal glands hyperplasic and no alteration of the pituitary image. The tumour was located between the two layers 
of the meso-colon and was removed using laparoscopy. After surgery, ACTH concentrations became normal and 
clinical signs remitted. The histopathological diagnosis was NET, with positive ACTH immunostaining.
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Cushing’s syndrome (CS) is a frequent endo-
crine pathology in the dog. Its main cause is exces-
sive production of adrenocorticotropic hormone 
(ACTH) by a corticotroph-cell adenoma. It can also 
arise from tumours in one of the adrenal glands, 
though recently the presence of illegitimate re-
ceptors in these glands is also considered a source 
(Kooistra and Galac 2012). In humans ectopic 
ACTH secretion can be associated with various 
solid tumours, mostly of neuroendocrine origin and 
has been called Ectopic ACTH syndrome (EAS) 
(Alexandrakis and Grossman 2010; Newell-Price 
et al. 1998; Isidori and Lenzi 2007; Pivonello et al. 
2008). There are few registered cases in dogs, one 
of which was reported by Churcher (1999) and an-
other more recent case by Galac et al. (2005), with 
no other cases reported to the best of the authors’ 
knowledge.
Neuroendocrine tumours (NET) or apudomas are 
characterised by cells that capture amine precur-
sors (Amine Precursor Uptake Decarboxylase cells, 
APUD) and by decarboxylation convert the amines 
into peptides with different functions. These tumours 
are most frequently located in the endocrine pan-
creas (insulinomas and glucagonomas), the adrenal 
medulla (pheochromocytomas), intestines and lungs. 
Other locations have been described for neuroen-
docrine tumours in dogs, although extremely rarely 
(Patnaik et al. 1981; Harkema et al. 1992; Sako et al. 
2005; Vergine et al. 2005; Kuwata et al. 2010) and are 
not associated with ACTH secretion or with clinical 
symptoms compatible with hypercortisolism.
This report concerns a dog diagnosed with CS in-
voked by an extra-adrenal, extra-pituitary tumour 
that we discovered to be an ACTH-secreting NET 
located in the mesentery. 
Case description
Clinical case. The patient was an eight-year-old 
crossbreed spayed female of medium size (10.5 kg) 
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that was referred to our hospital from Uruguay 
with a clinical diagnosis of Cushing’s syndrome. 
The owner described an increase in weight and 
abdomen size over the last four months, and had 
noted polyuria-polydipsia and polyphagia in the last 
30 days before consulting. Routine laboratory results 
(Table 1) showed alteration of the following param-
eters: hepatic enzymes, electrolytes (Na and K) and 
glycaemia, all within the reference range of values of 
the acting laboratory. The urine cortisol/creatinine 
ratio (UCCR) was determined in order to screen for 
CS (Rijnberk et al.1988; Kooistra and Galac 2012), 
and gave a value of 93 × 10–6 (reference value < 10 × 
10–6). Once the diagnosis of CS was suspected, inhi-
bition with low dose dexamethasone intravenously 
(i.v.) was conducted (Feldman et al.1996) as a di-
agnostic and differential test, showing no inhibi-
tion at 4 h and 8 h (basal cortisol: 185 nmol/l; 4 h: 
183.4 nmo/l; 8 h: 217.4 nmol/l). Based on these 
results, ultrasonographic evaluation of the abdo-
men was indicated which revealed the presence of 
a hypoechogenic formation of 5.2 cm with irregular 
borders in the left hemi-abdomen, associated with 
the area of the left adrenal gland. Owing to the 
suspicion of neoplasia in the left adrenal gland, the 
owner was advised to take the case to a hospital 
in Buenos Aires, Argentina for adrenalectomy and 
post-surgical follow-up.
Computed tomography. A computed tomog-
raphy (CT) of the sellar area (3 mm serial coronal 
sections every 9 s of scanning), of the abdomen 
in general and the adrenal glands in particular 
(3 mm serial transversal sections of 5 s scanning) 
with the dog in sternal recumbence was indicated 
prior to surgery. The study was carried out with 
and without i.v. iodine contrast medium (Telebrix® 
Coronario, Temis Lostalo, Argentina).
The results of the study indicated that both adre-
nal glands preserved their shape and were hyper-
plastic (right adrenal gland: 8 × 7 mm; left adrenal 
gland: 12 × 14 mm). In the left epi-mesogastric 
region the presence of a 5 × 6 cm high and 8 cm long 
tumour was reported (Figure 1). It was unrelated 
to any adjacent organ, showing smooth slightly 
irregular borders. The images of the rest of the 
abdominal structures did not reveal any alteration 
except for hepatomegaly, typical of CS. Exploration 
of the sellar region showed the pituitary and the 
rest of the encephalic parenchyma to be without 
any morphological alterations. Additionally, due to 
the discovery of the extra-adrenal tumour, explora-
tion of the thorax was carried out. All structures 
therein were of normal morphology.
Endocrine biochemistry. Based on the CT re-
port, it was suspected that the CS might be caused 
by ectopic ACTH secretion. Therefore, measure-
ments of this hormone and of cortisol, to be carried 
out in the same plasma sample, were requested. 
ACTH and cortisol were measured before surgery 
and this was repeated at the time of discharge from 
the hospital (four days after surgery) before return-
ing to the country of origin. For both hormones, 
the blood sample was collected into refrigerated 
plastic tubes with anticoagulant (EDTA) and apro-
Figure 1. Computed tomography image. A = left adrenal gland (arrow) and B = right adrenal gland (arrow) and the 
tumour mass (circle) in the left hemi-abdomen; L = left; R = right
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tinin and immediately centrifuged. The serum 
was then stored at –30 °C until the assays were 
carried out. Hormone analyses were carried out 
in the Biochemistry laboratory of the Veterinary 
Medicine Hospital of the Faculty of Veterinary 
Sciences of the University of Buenos Aires using 
enzyme immunoassay commercial kits from Alpco 
Diagnostics (Windham, NH, USA). For ACTH, the 
Adrenocorticotropic hormone Elisa (ACTH Elisa) 
was used, with an intra- and inter-assay coefficient 
of variation of 6.7 and 7.1%, respectively, and with 
a sensitivity of 0.46 pg/ml. For cortisol, a Cortisol 
ELISA was used, with an intra- and inter-assay co-
efficient of variation of 5.0% and 8.1%, respectively, 
and a sensitivity of 0.4 µg/dl.
The CRH test which discriminates between pi-
tuitary-dependent and ectopic ACTH (Nieman et 
al. 1993; Isidori et al. 2003) could not be carried 
out owing to the lack of necessary reagents in our 
country.
Laparotomy. The patient was subjected to mid-
line abdominal surgery and a 5 × 7cm high-width 
and 9 cm long tumour, located in the epigastrium-
meso-gastrium region between the two layers of 
the meso-colon, was removed. The tumour was 
situated close to the left adrenal gland, was very 
vascularised and had distinct irregular borders. The 
pancreas, kidneys, duodenum, colon, stomach, ab-
dominal lymph nodes and liver were all carefully 
explored and neither metastasis nor other evident 
alterations were found, except for hepatomegaly 
which had already been observed in the ultrasound 
and CT evaluations. Therefore, the mass was con-
sidered a primary tumour.
The patient was released 72 h post surgery and 
returned to Uruguay 48 h later (5th day after sur-
gery) where clinical and biochemical follow-up was 
carried out.
Histopathology and immunohistochemistry. 
The tumour was examined using histopathology 
(haematoxylin-eosin staining) and immunohisto-
chemistry (IHC) in 10% buffered formalin, with 
an indication for ACTH staining due to the sus-
picion of ectopic ACTH secretion. Sections of 
3 µm were stained with haematoxylin-eosin (HE). 
Immunohistochemical staining was performed us-
ing the avidin-biotin complex (ABC) and the im-
munoperoxidase detection system (Millipore IHC 
Select) technique, using a mouse monoclonal an-
tibody (1 : 400 in PBS) against the one to 24 amino 
acid region of ACTH (Santa Cruz Biotechnology, 
SPM333). The chromogen 3,3'-diaminobenzidine 
(DAB) was used for revealing. A DC180 digital 
camera and a tri-ocular DMLS Leica microscope 
were used to capture the images.
Ethical approval. The Ethics Committee of 
the Faculty of Veterinary Science (CICUAL) ap-
proved the present study, according to the laws 
on experimentation in animals in Argentina and 
World Health Organization recommendations. The 
signed consent of the dog’s owner was obtained 
for conducting the requested studies, surgery and 
publication of the data.   
RESULTS
Endocrine biochemistry
Prior to surgery, plasma ACTH concentration 
was 28.6 pmol/l (reference value in our laborato-
ry: 5.5–14.3 pmol/l) and cortisol was 220.7 nmol/l 
(reference value: 22.07–110.4 nmol/l). Plasma con-
centrations of ACTH decreased to 11 pmol/l and 
cortisol to 88.3 nmol/l in the samples obtained four 
days after surgery.
Histopathology and immunohistochemistry
The histopathological report identified polygonal-
cuboidal cells that were grouped forming rosettes 
and a pseudo alveolar structure, with a vascularised 
fibrous stroma of carcinoid aspect, nuclei largely 
hyperchromatic and atypical and with eosinophilic 
cytoplasm, all compatible with a neuroendocrine 
tumour (Ashley 1990). Immunohistochemistry was 
positive for ACTH, showing strong and diffuse nu-
clear and cytoplasmic immunoreactivity of the tu-
mour cells to the anti-ACTH antibody (Figure 2).
Clinical evolution after surgery
Five days after surgery, prior to returning to 
Uruguay, the owner conveyed that solid and liquid 
intake had returned to normal. Ten days after sur-
gery, a control electrolyte analysis was carried out, 
showing a slight hyperkalaemia (5.8 mEq/l, refer-
ence value: 3.7–5.5 mEq/l) with normal natraemia 
(140 mEq/l, reference value: 140–155 mEq/l), but 
altered Na/K ratio of 24.1/1 (reference value be-
tween 27/1 and 31/1), and no clinical expression of 
adrenal insufficiency. Because of the altered Na/K 
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ratio and possible risk of adrenal insufficiency, hy-
drocortisone was indicated: 0.5mg/kg every 12 h 
for three days, followed by the same dose once a 
day for three more days, then 0.25 mg/kg/day for 
three days and finally, this same dose every 48 h 
(last three doses). The day after suspending the 
hydrocortisone administration, electrolyte analysis 
was repeated, showing normal values for Na, K and 
the Na/K ratio (148 mmol/l, 4.2 mmol/l and 35.2/1, 
respectively). Sixty days after surgery, evaluation 
back in the owner’s own country revealed a reduc-
tion in abdomen and weight (8.700 kg) and no clini-
cal symptoms compatible with CS. Biochemistry 
results at this time showed a decrease in hepatic 
enzymes, an electrolyte analysis with no alterations 
and normal glycaemia (Table 1). A year after sur-
gery (evaluated in Uruguay) the patient remained 
stable, without clinical signs of a recurrence of the 
pathology and with a normal biochemical analysis.
DISCUSSION AND CONCLUSIONS
In this report, we describe a CS due to ectopic 
ACTH secretion by a NET found in the abdomen 
located in the meso-colon, confirmed by IHC.
Similar cases have been reported by Churcher 
(1999) and Galac et al. (2005), both of which are 
similar to the present case in certain aspects and 
different in others. With regard to the location of 
the NET, in the case reported by Churcher (1999), 
the hypercortisolism was associated with the pres-
ence of a hepatic carcinoid, while the case reported 
by Galac et al. (2005) was related to a NET located 
in the pancreas. In our study, the tumour did not 
belong to any organ in particular, and was located 
in the mesentery. Other authors have also reported 
cases of NET associated with ectopic ACTH se-
cretion with infrequent or unusual presentations 
(Johnson 1982; Otsuka et al. 2005; Thomas et al. 
2013). The most frequent locations for the ACTH-
secreting carcinoid are the lungs, pancreas, thy-
roid and adrenal medulla (Clark and Carney 1987; 
Terzolo et al. 2001; Otzuka et al. 2005).
With respect to similarities, none of the three 
cases showed cortisol suppression after dexametha-
sone administration because the axis was already 
inhibited (Churcher 1999; Galac et al. 2005). The 
lack of dexamethasone inhibition is to be expected 
in cases of adrenal neoplasias and of pituitary mac-
roadenomas (Kooistra et al. 1997; Newel-Price et 




60 days 1 year
AP (UI/l) 1250 450 200
GPT/ALT (UI/l) 120 60 36
GOT/AST (UI/l) 55 32 45
Glucose (mmol/l) 5.9 3.8 4.8
Na+ (mEq/l) 147 157 152
K+ (mEq/l) 5.0 4.8 5.2
AP = alkaline phosphatase (normal value: up to 300 UI/l); 
GPT/ALT = pyruvic glutamate transaminase/alanine ami-
notransferase (normal value: up to 50 UI/l); GOT/AST = oxa-
lacetic glutamate transaminase/aspartate aminotransferase 
(normal value: up to 50 UI/l); glucose (normal value: 3.4–
6.2 mmol/l); Na = sodium (normal value: 140–155 mEq/l), 
K = potassium (normal value: 3.7–5.5 mEq/l)
Figure 2. Histopathology (a) and IHC (b, c). (a) The disposition of the neoplastic cells, forming groups some like cords 
and others like rosettes, with very pycnotic nuclei, can be seen by H-E (40×). (b) Negative control of ICH (stained 
with hematoxylin), (c) brown positive staining for ACTH in both nucleus and cytoplasm. Polyclonal anti ACTH anti-
body, ABC method, hematoxylin counterstain (40×)
(a) (b) (c)
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al. 1998; Kooistra and Galac 2012), both scenarios 
having been ruled out after the image studies were 
carried out. Nevertheless, in human medicine, this 
lack of suppression of the axis together with nega-
tive images for the pituitary and adrenal glands 
make it necessary to rule out the presence of car-
cinoids that can produce EAS (Newell-Price 1998; 
Newell-Price 2006).
In the CT study, the pituitary image was normal, 
with both adrenal glands hyperplasic, similarly to 
what has been reported in dogs. The finding of 
an intra-abdominal tumour mass in addition to 
clinical and biochemical features of CS led to the 
suspicion of ectopic ACTH secretion, which was 
clinically confirmed by the high plasma levels of 
ACTH and cortisol. In the cases of EAS report-
ed in human medicine, plasma concentrations of 
both hormones are characteristically higher than 
in pituitary-dependent Cushing patients (Howlett 
et al. 1986; Newel-Price et al 2006; Alexandrakis 
and Grossamn 2010; Ma et al. 2010). High concen-
trations of ACTH without evidence of a pituitary 
tumour are suggestive of EAS according to previ-
ous reports. In human medicine, the CRH test is 
indicated to differentiate between corticotroph ad-
enoma and ectopic ACTH secretion. The majority 
of patients with EAS do not respond to CRH, but 
some do respond normally (Malchoff et al. 1988; 
Neiman et al. 1993; Isidori et al. 2003). In veterinary 
medicine, only in the case reported by Galac et al. 
(2005) was this test performed. Unfortunately, in our 
country the CRH is unavailable commercially and 
the test could not be performed. Thus, the plasma 
ACTH and cortisol concentrations were taken into 
account as suggestive of EAS. Our findings of plasma 
ACTH and cortisol without the imaging of a pitui-
tary tumour and our discovery of an extra-adrenal 
tumour in the abdomen are in agreement both with 
reports in human medicine and the results of Galac 
et al. (2005). In the case of Churcher (1999), ACTH 
concentrations were within the reference values 
given by the author, this being an unexpected pat-
tern for a case of ectopic ACTH secretion.
Potassium levels were normal in our case; in con-
trast, according to human reports and those of Galac 
et al. (2005) and Churcher (1999), hypokalaemia 
would be expected (Howlet et al. 1986; Ulick et al. 
1992; Isidori and Lenzi 2005). It is possible that the 
relatively short period of time between the appear-
ance of clinical symptoms, diagnosis and treatment 
did not allow time for the proposed mechanisms 
leading to hypokalaemia to develop. The altered 
electrolyte levels compatible with adrenal insuffi-
ciency, which were observed later and which neces-
sitated hydrocortisone supplementation for a short 
period, can be explained by the rapid decrease in 
ACTH after the tumour was removed. The ACTH 
stimulation test could not be performed in order 
to confirm the adrenal insufficiency owing to con-
siderations of time: the owner’s dog remained in 
Buenos Aires in order to establish hydrocortisone 
therapy based on the results of the ionogram, which 
were suggestive of adrenal insufficiency. The fact 
that this episode was not repeated after suspending 
hydrocortisone administration and that electrolyte 
analysis remained normal indicates that pituitary 
secretion of ACTH (once excess cortisol from the 
ectopic ACTH was inhibited) returned to normal, 
as did the pituitary axis.
The substantial difference with the other two 
reports in dogs is that the IHC for ACTH was 
positive, indicating that the tumour was producing 
the hormone through a subpopulation of ACTH-
secreting tumour cells, thus representing a clear 
case of ectopic ACTH syndrome. In the other two 
reports mentioned above, the IHC failed to stain 
positive for ACTH, which is possible in these situa-
tions and has also been reported in humans (Coates 
et al. 1986; Alexandrakis and Grossman 2010). 
The fact that after the removal of the tumour 
the clinical symptoms produced by the hypercor-
tisolism remitted totally and that both hepatic 
enzymes and ACTH and cortisol concentrations re-
turned to normal without the need for adrenal cor-
tex inhibition therapy confirms that the cause of the 
CS was the abdominal tumour, with no metastasis 
nor other adrenal or pituitary tumours present at 
the time of the surgery. This is an important point 
because in the case reported by Galac et al. (2005), 
there was metastasis of the primary tumour and it 
was necessary to administer trilostane to control 
the hypercortisolism and in the case reported by 
Churcher (1999), the dog died after the surgery.
To conclude, in cases of CS that fail to react to 
dexamethasone inhibition and are not character-
ised by the presence of a pituitary or adrenal tu-
mour (evaluated using computed tomography, for 
example), the possibility of ectopic ACTH secre-
tion by a NET should be taken into account. High 
plasma ACTH and cortisol levels may point to a 
NET and it is still important to perform the CRH 
test, if available, as is done in human medicine. 
Exploration of the abdomen and thorax with sen-
sitive imaging methods (magnetic resonance and/
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or scintigraphy with octreotide) to detect the pos-
sibility of carcinoids should be considered in these 
cases. Lastly, ectopic ACTH secretion as an under-
lying cause of CS in the dog should be considered 
as a potential aetiology for this disease.
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